Detalhe da pesquisa
1.
Heart Failure End Points in Cardiovascular Outcome Trials of Sodium Glucose Cotransporter 2 Inhibitors in Patients With Type 2 Diabetes Mellitus: A Critical Evaluation of Clinical and Regulatory Issues.
Circulation
; 140(25): 2108-2118, 2019 12 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-31841369
2.
Clinical and Echocardiographic Characteristics and Cardiovascular Outcomes According to Diabetes Status in Patients With Heart Failure and Preserved Ejection Fraction: A Report From the I-Preserve Trial (Irbesartan in Heart Failure With Preserved Ejection Fraction).
Circulation
; 135(8): 724-735, 2017 Feb 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-28052977
3.
Risk of stroke in chronic heart failure patients with preserved ejection fraction, but without atrial fibrillation: analysis of the CHARM-Preserved and I-Preserve trials.
Eur Heart J
; 38(10): 742-750, 2017 Mar 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-28426886
4.
Prognostic Value of Insulin-Like Growth Factor-Binding Protein 7 in Patients with Heart Failure and Preserved Ejection Fraction.
J Card Fail
; 23(1): 20-28, 2017 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-27317843
5.
International geographic variation in event rates in trials of heart failure with preserved and reduced ejection fraction.
Circulation
; 131(1): 43-53, 2015 Jan 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-25406306
6.
Heart Failure in Non-Caucasians, Women, and Older Adults: A White Paper on Special Populations From the Heart Failure Society of America Guideline Committee.
J Card Fail
; 21(8): 674-93, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-26051012
7.
Advanced (stage D) heart failure: a statement from the Heart Failure Society of America Guidelines Committee.
J Card Fail
; 21(6): 519-34, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25953697
8.
Low Natriuretic Peptide Levels and Outcomes in Patients With Heart Failure and Preserved Ejection Fraction.
JACC Heart Fail
; 2024 Jun 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-38904646
9.
Left Ventricular Ejection Fraction and the Future of Heart Failure Phenotyping.
JACC Heart Fail
; 12(3): 451-460, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38099892
10.
Important differences in mode of death between men and women with heart failure who would qualify for a primary prevention implantable cardioverter-defibrillator.
Circulation
; 126(20): 2402-7, 2012 Nov 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-23072904
11.
Acute decompensated heart failure: update on new and emerging evidence and directions for future research.
J Card Fail
; 19(6): 371-89, 2013 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-23743486
12.
Prevalence and significance of alterations in cardiac structure and function in patients with heart failure and a preserved ejection fraction.
Circulation
; 124(23): 2491-501, 2011 Dec 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-22064591
13.
Indications for cardiac resynchronization therapy: 2011 update from the Heart Failure Society of America Guideline Committee.
J Card Fail
; 18(2): 94-106, 2012 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-22300776
14.
Update on aldosterone antagonists use in heart failure with reduced left ventricular ejection fraction. Heart Failure Society of America Guidelines Committee.
J Card Fail
; 18(4): 265-81, 2012 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-22464767
15.
Mode of death in patients with heart failure and a preserved ejection fraction: results from the Irbesartan in Heart Failure With Preserved Ejection Fraction Study (I-Preserve) trial.
Circulation
; 121(12): 1393-405, 2010 Mar 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-20231531
16.
Irbesartan in patients with heart failure and preserved ejection fraction.
N Engl J Med
; 359(23): 2456-67, 2008 Dec 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-19001508
17.
Developing and validating models to predict sudden death and pump failure death in patients with heart failure and preserved ejection fraction.
Clin Res Cardiol
; 110(8): 1234-1248, 2021 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-33301080
18.
Treatment of HF in an Era of Multiple Therapies: Statement From the HF Collaboratory.
JACC Heart Fail
; 9(1): 1-12, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33309582
19.
Uric acid level and allopurinol use as risk markers of mortality and morbidity in systolic heart failure.
Am Heart J
; 160(5): 928-33, 2010 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-21095282
20.
Safety, Performance, and Efficacy of Cardiac Contractility Modulation Delivered by the 2-Lead Optimizer Smart System: The FIX-HF-5C2 Study.
Circ Heart Fail
; 13(4): e006512, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32264716